BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20240904T100000
DTEND;TZID=Europe/Helsinki:20240904T103000
DTSTAMP:20260411T225405
CREATED:20240822T150659Z
LAST-MODIFIED:20241024T183101Z
UID:10000797-1725444000-1725445800@staging.digitalinsights.supremeclients.com
SUMMARY:Achieving Good Manufacturing Production (GxP) compliance with NGS (EMEA)
DESCRIPTION:New guidelines for the viral safety evaluation of biotechnology products from the International Council for Harmonisation (ICH) recommend replacing multiple in vivo and in vitro assays with next-generation sequencing (NGS) to maintain good manufacturing practices. \nIf that sounds like a lot\, we’ve got you covered. In this webinar\, we’ll explore how you can easily apply NGS analysis to GxP with the QIAGEN CLC Genomics platform. Make compliance intrinsic to your workflow and ensure product quality\, data integrity and patient safety. \nYou’ll learn how to: \n\nAssess biosafety\, ensure integrity and perform quality control in the biotech industry with NGS\nImplement and maintain GxP with the QIAGEN CLC Genomics platform\nAdd your existing applications and extend their use through the CLC interface
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/achieving-good-manufacturing-production-gxp-compliance-with-ngs-emea/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_9299_QDI_CLC_Gi973088652_16x9_Large-1200px_49128-1140x641-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240904T130000
DTEND;TZID=America/Halifax:20240904T133000
DTSTAMP:20260411T225405
CREATED:20240822T151120Z
LAST-MODIFIED:20241024T183101Z
UID:10000798-1725454800-1725456600@staging.digitalinsights.supremeclients.com
SUMMARY:Achieving Good Manufacturing Production (GxP) compliance with NGS (Americas)
DESCRIPTION:New guidelines for the viral safety evaluation of biotechnology products from the International Council for Harmonisation (ICH) recommend replacing multiple in vivo and in vitro assays with next-generation sequencing (NGS) to maintain good manufacturing practices. \nIf that sounds like a lot\, we’ve got you covered. In this webinar\, we’ll explore how you can easily apply NGS analysis to GxP with the QIAGEN CLC Genomics platform. Make compliance intrinsic to your workflow and ensure product quality\, data integrity and patient safety. \nYou’ll learn how to: \n\nAssess biosafety\, ensure integrity and perform quality control in the biotech industry with NGS\nImplement and maintain GxP with the QIAGEN CLC Genomics platform\nAdd your existing applications and extend their use through the CLC interface
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/achieving-good-manufacturing-production-gxp-compliance-with-ngs-americas/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_9299_QDI_CLC_Gi973088652_16x9_Large-1200px_49128-1140x641-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240904T130000
DTEND;TZID=America/Halifax:20240904T150000
DTSTAMP:20260411T225405
CREATED:20240814T191059Z
LAST-MODIFIED:20241024T183058Z
UID:10000790-1725454800-1725462000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN IPA new user training
DESCRIPTION:Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. \nYou’ll learn to: \n\nUpload multiple dataset types (e.g.\, RNA-seq\, proteomics\, metabolomics) and perform interactive core/pathway analysis in IPA\nLearn how to interpret different results\, including pathways\, key regulators\, impact on biological functions/diseases and more\nCompare different experimental conditions (e.g.\, single-cell clusters\, disease types) and identify similarities and contrasts\nGenerate a network for hypothesis generation\, even without a dataset or experimental design\n\nAlready have an IPA license? Install IPA and start using it now. \nLearn more about IPA or request a free trial.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ipa-new-user-training/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
END:VCALENDAR